GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies

NCT04937153 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: Acasunlimab
BIOLOGICAL: Pembrolizumab

Sponsor

Genmab